Joyce F Liu (Joyce Liu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 25

Top Topics

Combination Therapy

Endometrial Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandre Andre Balieiro Anastacio da Costa, Ozge Somuncu, Ramya Ravindranathan, Sirisha Mukkavalli, David B Martignetti, Huy Nguyen, Yuqing Jiao, Benjamin P Lamarre, Golbahar Sadatrezaei, Lisa A Moreau, Joyce F Liu, Divya Ramalingam Iyer, Jean-Bernard Lazaro, Geoffrey I Shapiro, Kalindi Parmar, Alan D' Andrea
Single-stranded DNA Gap Accumulation is a Functional Biomarker for USP1 Inhibitor Sensitivity. Cancer research (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre Andre Balieiro Anastacio da Costa, Doga C Gulhan, Andrea E Wahner Hendrickson, Bose S Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D' Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 8 (2024)
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre Andre Balieiro Anastacio da Costa, Doga C Gulhan, Andrea E Wahner Hendrickson, Bose S Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D' Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 8 (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Alexandre Andre Balieiro Anastacio da Costa, Ozge Somuncu, Ramya Ravindranathan, Sirisha Mukkavalli, David B Martignetti, Huy Nguyen, Yuqing Jiao, Benjamin P Lamarre, Golbahar Sadatrezaei, Lisa A Moreau, Joyce F Liu, Divya Ramalingam Iyer, Jean-Bernard Lazaro, Geoffrey I Shapiro, Kalindi Parmar, Alan D' Andrea
Single-stranded DNA Gap Accumulation is a Functional Biomarker for USP1 Inhibitor Sensitivity. Cancer research (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joyce F Liu, Stephanie Gaillard, Andrea E Wahner Hendrickson, Oladapo O Yeku, Elisabeth Diver, Camille Gunderson Jackson, Rebecca Arend, Elena Ratner, Vivek Samnotra, Divya Gupta, Jon Chung, Hailei Zhang, Natalie Compton, Amanda Baines, Emeline Bacqué, Xiaohong Liu, Brunella Felicetti, Gottfried E Konecny
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial. JCO precision oncology 8 (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Joyce F Liu, Stephanie Gaillard, Andrea E Wahner Hendrickson, Oladapo O Yeku, Elisabeth Diver, Camille Gunderson Jackson, Rebecca Arend, Elena Ratner, Vivek Samnotra, Divya Gupta, Jon Chung, Hailei Zhang, Natalie Compton, Amanda Baines, Emeline Bacqué, Xiaohong Liu, Brunella Felicetti, Gottfried E Konecny
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial. JCO precision oncology 8 (2024)
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre Andre Balieiro Anastacio da Costa, Doga C Gulhan, Andrea E Wahner Hendrickson, Bose S Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D' Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 8 (2024)
Jung-Min Lee, Joyce F Liu
One fixed dosing of a poly(adenosine diphosphate ribose) polymerase inhibitor does not fit all. Cancer (2023)
Jessica D St Laurent, Joyce F Liu
Treatment Approaches for Platinum-Resistant Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Joyce F Liu, Mark F Brady, Ursula A Matulonis, Austin Miller, Elise C Kohn, Elizabeth M Swisher, David Cella, William P Tew, Noelle G Cloven, Carolyn Y Muller, David P Bender, Richard G Moore, David P Michelin, Steven E Waggoner, Melissa A Geller, Keiichi Fujiwara, Stacy D D'Andre, Michael E Carney, Angeles A Secord, Katherine M Moxley, Michael A Bookman
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Jung-Min Lee, Richard G Moore, Sharad A Ghamande, Min S Park, John P Diaz, Julia Chapman, James Kendrick, Brian M Slomovitz, Krishnansu S Tewari, Elizabeth S Lowe, Tsveta Milenkova, Sanjeev Kumar, Mike Dymond, Jessica Brown, Joyce F Liu
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Susana Campos, David L Kolin, Joyce F Liu, Neil Horowitz, Alexi A Wright, Sara Bouberhan, Richard T Penson, Oladapo O Yeku, Brittany Bowes, Hope Needham, Martin Hayes, Hannah Sawyer, Madeline Polak, Meghan Shea, Su-Chun Cheng, Cesar M Castro, Ursula A Matulonis
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Paul A DiSilvestro, Susana Banerjee, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael L Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Amit M Oza, Antonio Gonzáles Martin, Carol Aghajanian, William H Bradley, Cara A Mathews, Joyce F Liu, John McNamara, Elizabeth S Lowe, Mei-Lin Ah-See, Kathleen M Moore, null null
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jeffrey Patterson-Fortin, Arindam Bose, Wei-Chih Tsai, Carter Grochala, Huy Nguyen, Jia Zhou, Kalindi Parmar, Jean-Bernard Lazaro, Joyce F Liu, Kelsey McQueen, Geoffrey I Shapiro, David E Kozono, Alan D' Andrea
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers. Cancer research 82 (20) (2022)
Joyce F Liu, Amit M Oza, Nicoletta Colombo, Ana Oaknin
ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
Joyce F Liu, Niya Xiong, Susana M Campos, Alexi A Wright, Carolyn Krasner, Susan Schumer, Neil Horowitz, Jennifer Veneris, Nabihah Tayob, Stephanie Morrissey, Gabriela West, Roxanne Quinn, Ursula A Matulonis, Panagiotis A Konstantinopoulos
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)